CME Group Inc. (NASDAQ:CME – Get Free Report) Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
CME Group Stock Performance
CME stock traded up $1.69 during trading on Tuesday, reaching $265.85. 560,777 shares of the company’s stock were exchanged, compared to its average volume of 2,211,024. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The company’s fifty day moving average price is $265.69 and its 200-day moving average price is $272.18. The firm has a market cap of $95.87 billion, a PE ratio of 25.75, a P/E/G ratio of 4.41 and a beta of 0.41.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted $2.68 EPS. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
Wall Street Analysts Forecast Growth
CME has been the subject of several research analyst reports. Raymond James Financial cut their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a report on Monday, October 13th. JPMorgan Chase & Co. boosted their target price on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Piper Sandler boosted their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Finally, Keefe, Bruyette & Woods boosted their target price on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $285.19.
Get Our Latest Analysis on CME Group
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Strategy Asset Managers LLC acquired a new position in CME Group during the third quarter valued at $646,000. Jones Financial Companies Lllp raised its position in CME Group by 25.0% during the third quarter. Jones Financial Companies Lllp now owns 10,702 shares of the financial services provider’s stock valued at $2,893,000 after buying an additional 2,143 shares during the period. United Community Bank raised its position in CME Group by 55.9% during the third quarter. United Community Bank now owns 329 shares of the financial services provider’s stock valued at $89,000 after buying an additional 118 shares during the period. Mawer Investment Management Ltd. raised its position in CME Group by 107.2% during the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after buying an additional 777,571 shares during the period. Finally, A4 Wealth Advisors LLC acquired a new position in CME Group during the third quarter valued at $283,000. 87.75% of the stock is owned by institutional investors and hedge funds.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Stock Market Upgrades: What Are They?
- Prediction Markets Are Coming: Can DraftKings & FanDuel Survive?
- Short Selling – The Pros and Cons
- Shopify Pullback Sets Stage for 20% Rally to $200 Target
- Using the MarketBeat Stock Split Calculator
- Roku’s Profit Engine Roars to Life: Is the Rally Just Beginning?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
